Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya. by Kedenge, Sarah V et al.
Njau, JD; Goodman, C; Kachur, SP; Palmer, N; Khatib, RA; Ab-
dulla, S; Mills, A; Bloland, P (2006) Fever treatment and household
wealth: the challenge posed for rolling out combination therapy for
malaria. Tropical medicine & international health , 11 (3). pp. 299-
313. ISSN 1360-2276
Downloaded from: http://researchonline.lshtm.ac.uk/11966/
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution Non-commercial No Derivatives
http://creativecommons.org/licenses/by-nc-nd/2.5/
Fever treatment and household wealth: the challenge posed
for rolling out combination therapy for malaria
J. D. Njau1, C. Goodman2, S. P. Kachur1,3, N. Palmer2, R. A. Khatib1, S. Abdulla1, A. Mills2 and P. Bloland4
1 Ifakara Health Research and Development Center, Ifakara, Tanzania
2 London School of Hygiene and Tropical Medicine, London, UK
3 Centers for Disease Control and Prevention Malaria Programme in Tanzania, Ifakara, Tanzania
4 Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Summary objective To investigate the variation in malaria parasitaemia, reported fever, care seeking,
antimalarials obtained and household expenditure by socio-economic status (SES), and to assess the
implications for ensuring equitable and appropriate use of antimalarial combination therapy.
methods A total of 2500 households were surveyed in three rural districts in southern Tanzania in
mid-2001. Blood samples and data on SES were collected from all households. Half the households
completed a detailed questionnaire on care seeking and treatment costs. Households were categorised
into SES thirds based on an index of household wealth derived using principal components analysis.
results Of individuals completing the detailed survey, 16% reported a fever episode in the previous
2 weeks. People from the better-off stratum were significantly less likely to be parasitaemic, and sig-
nificantly more likely to obtain antimalarials than those in the middle or poor stratum. The better
treatment obtained by the better off led them to spend two to three times more than the middle and poor
third spent. This reflected greater use of non-governmental organisation (NGO) facilities, which were
the most expensive source of care, and higher expenditure at NGO facilities and drug stores.
conclusion The coverage of appropriate malaria treatment was low in all SES groups, but the two
poorer groups were particularly disadvantaged. As countries switch to antimalarial combination ther-
apy, distribution must be targeted to ensure that the poorest groups fully benefit from these new and
highly effective medicines.
keywords antimalarials, combination therapy, equity, household, malaria, socio-economic status
Introduction
There have been increasing calls for better analysis of the
equity of access to and use of treatment for common but
potentially serious illnesses such as malaria (Barat et al.
2004). A few studies are available on socio-economic
status (SES) and treatment seeking for fever (Filmer 2002;
Armstrong Schellenberg et al. 2003). However, informa-
tion is very limited on the relationship between SES and the
appropriateness of care obtained and household costs,
although the latter may be central in explaining treatment
patterns.
Expanding the equitable coverage of appropriate malaria
treatment is a key priority in Africa in the context of the
Abuja target of 60% coverage of appropriate antimalarial
treatment in vulnerable groups (WHO/UNICEF 2003).
Moreover, in the face of increasing drug resistance prob-
lems, policymakers are concerned not just about the
proportion of care seekers obtaining antimalarials, but also
the proportion obtaining effective antimalarials. Growing
antimalarial resistance has led many African governments
to abandon chloroquine as first line treatment in favour of
other monotherapies, such as sulphadoxine/pyrimethamine
(SP), and increasingly governments are choosing artemis-
inin-based combination therapy (ACT). ACT is currently
10–20 times more expensive than widely used monother-
apies, but is highly efficacious. Moreover, evidence from
Thailand has demonstrated the potential of ACT to slow
the development of resistance to the component drugs
(White et al. 1999), although experience from Africa
remains very limited.
Tanzania represents a relatively typical East African
setting. The first line antimalarial treatment was changed
to SP in August 2001, and the introduction of ACT is
planned for 2006. A recent review reported that Tanzania
was unlikely to achieve the Abuja target for malaria
treatment (Malaria Consortium 2004), and little is known
about the equity of current treatment patterns. To assess
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the nature of the challenge involved in achieving high and
equitable levels of coverage with ACT, analysis of the
relationship between current provision and SES is neces-
sary. We present data on the relationship between SES and
care seeking, antimalarials obtained and household
expenditure, collected using a cross-sectional household
survey in three rural districts in south-eastern Tanzania.
The implications of the findings for strategies to ensure
equitable and appropriate use of ACT are considered.
Methods
Study Sites
The data were collected as part of the Interdisciplinary
Monitoring Project for Antimalarial Combination Therapy
in Tanzaniaa. Kilombero, Ulanga and Rufiji Districts are
located in Morogoro and Coast Regions in south-eastern
Tanzania, 150–400 km from Dar-es-Salaam. They are
geographically contiguous, but the Rufiji population is
separated from those in Kilombero and Ulanga by the
Selous Game Reserve. Median monthly household expen-
diture was under US$ 100 in these regions in 2002, and
about 75% of expenditure was on food (United Republic
of Tanzania, National Bureau of Statistics (2003))
(INDEPTH Network 2002). The main economic activity is
subsistence farming, supplemented by fishing and limited
cash-cropping. Many households migrate temporarily
during the main cultivation season to second houses close
to their farms.
There are typically two rainy seasons, the short rains in
October–December and the long rains in March–May,
although there is a year-to-year variation. Plasmodium
falciparum malaria transmission is intense and perennial in
all three districts, but there is seasonal variation reflecting
the rainfall patterns. Uncomplicated malaria is the leading
diagnosis for outpatient visits in all districts, and acute
febrile illness (including malaria) is a major cause of
mortality (INDEPTH Network 2002). Chloroquine
resistance is very high, with total treatment failureb in
under fives of 72% in Kilombero in 1999 (Ministry of
Health 1999). Resistance to SP was much lower, with
treatment failure of 6.8% in Rufiji and 6.3% in Ulanga in
2001 (MacArthur J.R. et al., unpublished data, IMPACT
collaboration).
The household survey was conducted in two areas
covered by demographic surveillance systems (DSS). The
first in Rufiji District contained 31 villages with a popu-
lation of 73 839 in 2001, and the second in Kilombero and
Ulanga Districts contained 25 villages with a population of
66 503. These rural populations were served by a mixture
of government and non-governmental organisation (NGO)
hospitals, health centres and smaller dispensaries, and
drugs were also widely available from drug stores and
general shops. The NGO facilities were owned by Chris-
tian organisations, except for one owned by an Islamic not-
for-profit organisation. There were no private for-profit
facilities in the study areas. As in most of rural Tanzania,
malaria diagnosis in the majority of healthcare facilities
and shops is based on the clinical symptoms alone, relying
mainly on reported fever. Government facilities are offi-
cially free in Rufiji, but in Kilombero and Ulanga user fees
have been introduced in dispensaries (but not in health
centres). The Integrated Management of Childhood Illness
(IMCI) was implemented in formal facilities in Rufiji from
1997, encompassing health worker guidelines, 11-day
training courses for staff treating children and system
support through improved supervision and commodity
supplies (Armstrong Schellenberg et al. 2004). Standard
case management remained in place in Kilombero and
Ulanga districts until 2002 when the IMCI model was
adopted in these areas as well.
Ethical approval and informed consent
The study received ethical approval from the institutional
review boards of the Ifakara Health Research and Devel-
opment Centre, the Tanzanian Medical Research Coordi-
nating Committee, the London School of Hygiene and
Tropical Medicine, and the US Centers for Disease Control
and Prevention. Before the start of all interviews, inter-
viewees were informed about the purpose of the research
and the nature of their participation. Written consent was
obtained from each interviewee, or from parents or
guardians on behalf of children. Sub-village leaders and
staff of the Council Health Management Teams (CHMT)
in each district were also informed.
a The Interdisciplinary Monitoring Project for Antimalarial
Combination Therapy in Tanzania (IMPACT-Tz) is a multiyear
implementation research evaluation project that rests on a colla-
borative platform comprising the US Public Health Service Centers
for Disease Control and Prevention (CDC), Ifakara Health
Research and Development Centre, the National Institute for
Medical Research, Muhimbili University College of Health
Sciences, the London School of Hygiene and Tropical Medicine
(UK), and the Tanzanian Ministry of Health, including its
National Malaria Control Programme, the Tanzania Essential
Health Interventions Project, the Adult Morbidity and Mortality
Project, and the Council Health Management Teams of Rufiji,
Morogoro, Kilombero and Ulanga Districts. IMPACT-Tz is
primarily supported by funding from CDC, the United States
Agency for International Development and Wellcome Trust.
b Total treatment failure includes parasitologic or clinical failure
within 14 days of treatment.
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Sample selection
A total of 2500 households was randomly selected, 1250
from Kilombero/Ulanga DSS and 1250 from Rufiji DSS,
drawing on the DSS household sampling frames. All
residents in each selected household were invited to
participate. A questionnaire was completed for each
household head and each resident (based on reports by the
primary caretaker for children under 12 years). To test for
malaria parasitaemia, finger prick blood samples were
obtained from each consenting household member for
thick and thin blood films, which were read by experienced
microscopists at central laboratories in Kilombero and
Rufiji. Households where one or more members were not
present were revisited once. Households that had closed,
declined participation, or where individuals were not
present on a second visit were not replaced.
At the time of selection, 50% of households were
randomly assigned to complete a more detailed question-
naire on care-seeking behaviour and treatment costs. The
results reported are drawn from this sub-sample (sample of
625 households in each DSS area), with the exception of
measures of relative household SES, which were calculated
across the whole sample.
Data collection
The survey was piloted in villages outside the DSS areas,
and all interviews were conducted in Swahili. Data were
collected by DSS staff between late May and September
2001, shortly after the season of heaviest rains. The overall
completion rate was 92% in Kilombero/Ulanga, and 83%
in Rufiji. In total, data were obtained for 2191 households,
of which 1101 were assigned the detailed questionnaire,
which was completed for 3851 individuals.
The questionnaire covered household and individual
characteristics and the incidence of ‘fever or malaria’ in the
previous 2 weeks.c The biomedical concept of uncompli-
cated malaria overlaps with the local illness concepts of
homa (usually translated as fever, although it can include
other symptoms), and maleria or homa ya maleria (Winch
et al. 1996; Minja et al. 2001). Respondents were there-
fore asked if they had experienced an episode of homa or
maleria. Individuals assigned to the detailed questionnaire
reporting fever or malaria were asked about the perceived
severity of the episode, associated symptoms, treatment
providers visited, care obtained and costs incurred. The
definition of provider was broad, including health facilities,
shops, traditional healers and any other sources used.
Data management and analysis
Data were double entered using FOXPRO 2.6a (Microsoft
Inc., Redmond, WA, USA), and checked for completeness,
logical consistency and coding errors. Analysis was per-
formed in stata version 8 (Stata Corp., College Station,
TX, USA), using survey commands (e.g. svytab, svymean)
to adjust for clustering between individuals in the same
household, and because separate samples were drawn from
Kilombero/Ulanga and Rufiji DSS systems. Population
weights were not used, as the sampling fractions in the two
DSS areas were almost equal (2.8% of the total DSS
population were interviewed in Kilombero/Ulanga and
2.7% in Rufiji). Differences in proportions were tested for
significance using the Pearson’s chi-squared statistic with
the Rao and Scott second-order correction to allow for
survey design. Regression analysis was performed using the
Huber/White/Sandwich estimators of variance (Stata Inc.
2003).
We assessed the proportion of individuals reporting
fever/malaria who obtained an antimalarial and an
‘effective’ antimalarial, the latter excluding chloroquine
because of the high levels of resistance to this drug.
Adequate dosing was assessed on the basis of the propor-
tion of individuals obtaining at least a minimum dose
according to age-specific national treatment guidelines or
IMCI standard dose recommendation guidelines. Where
individuals obtained more than one antimalarial of the
same generic type (e.g. two sets of chloroquine tablets, or
quinine tablets and quinine injections), the doses were
summed to assess adequacy. The frequency of over-dosing
and the timing of doses were not assessed, as data were
collected on drugs obtained from providers, rather than
those consumed.
Measuring socio-economic status
A relative index of household SES was derived based on 19
dichotomous variables using principal components analysis
(PCA) (Filmer & Pritchett 2001; McKenzie 2003). This
technique generates an index providing maximum dis-
crimination between households, which is normally dis-
tributed with a mean of zero and SD of one. The variables
included were a combination of household construction
(walls, roof and floor), utilities (sources of water, light and
cooking fuel, use of toilet), and ownership of assets
(livestock, bed, clock/watch, mattress, iron, mosquito net,
radio, clothing cupboard, bicycle, sofa, motorbike and car/
tractor).
The index was calculated across all surveyed households.
The first principal component explained 21% of the
variability in the SES variables, a similar proportion to that
c Including episodes which began more than 2 weeks previously
that continued into the recall period.
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explained in other such analyses (Filmer & Pritchett 2001;
Armstrong Schellenberg et al. 2003; McKenzie 2003). All
variables had the expected positive association with SES,
with the exception of having a private water supply. It is
possible that this may reflect a higher probability of sharing
a water supply in areas of higher population density, where
households may tend to be relatively better-off. The assets
which made the greatest change to the PCA score were
ownership of a sofa or clothing cupboard, floor construc-
tion and cooking fuel (Table 1).
The PCA scores ranged from )2.46 to 8.67. Households
were classified on the basis of their PCA score into SES
thirds of poorest, middle or better-off, with mean PCA
scores of )1.6, )0.6 and 2.2, respectively. SES thirds rather
than quintiles or deciles were used because the distribution
of PCA scores was highly skewed to the left making it
difficult to make fine distinctions between the SES status of
poorer households. SES data were incomplete for 46
households and 154 individuals assigned the detailed
questionnaire (4%), of whom 29 (18.3%) had reported
fever/malaria. Throughout the paper, results are presented
only for the individuals with complete SES information.
Principal components analysis scores were not adjusted
for household size, as the benefits of household construc-
tion, utilities and many durable assets were available at the
household level (McKenzie 2003). Average household size
was slightly higher among households of higher SES,
meaning that, although households were equally distri-
buted between SES thirds by definition, 37% of individuals
interviewed were in the better-off third, compared with
30% in the poorest third.
Results
Basic characteristics of households and individuals com-
pleting the detailed survey are presented in Table 2 by SES.
Households where the head’s main occupation was off-
farm had significantly higher PCA scores than those mainly
engaged in farming, with 23% of households in the better-
off third mainly engaged in off-farm activities, and only
3% in the poorest third. There was a significant correlation
between the years of education of household head and PCA
score (r ¼ 0.4, t-test, P < 0.0001), with 18% of household
heads in the better-off third having more than primary
education, compared with only 3% in the poorest third.
There were no significant differences between the two DSS
areas in the proportion of households in each SES third, or
in the mean PCA score; nor were there significant
Table 1 Results of principal components
analysis of household socio-economic status
(SES) variables
Variable definition* Mean SD Weight Impact on PCA score
Floor of tiles/cement 0.12 0.322 0.35 1.09
Walls of fired bricks/cement 0.21 0.409 0.27 0.66
Roof of tiles/cement/corrugated iron 0.26 0.437 0.31 0.71
Cooking fuel is electricity/
gas/kerosene/charcoal
0.09 0.284 0.30 1.06
Water source is private pipe,
well or pump
0.18 0.383 )0.05 )0.13
Household has use of toilet 0.97 0.169 0.03 0.18
Light source is electricity/
hurricane lamp
0.14 0.351 0.31 0.88
Household owns at least one:
Bed 0.95 0.224 0.07 0.31
Watch/clock 0.35 0.476 0.24 0.50
Mattress 0.33 0.469 0.32 0.68
Iron 0.11 0.314 0.28 0.89
Mosquito net 0.54 0.499 0.16 0.32
Radio 0.49 0.500 0.24 0.48
Clothing cupboard 0.05 0.217 0.28 1.29
Bicycle 0.44 0.496 0.17 0.34
Livestock 0.58 0.494 0.05 0.10
Sofa 0.04 0.201 0.28 1.39
Motorbike 0.005 0.068 0.01 0.15
Car 0.003 0.053 0.04 0.75
* Households were allocated one if at least some of their construction materials or light/
cooking fuel fell in these categories.
 Impact of a change from 0 to 1 for each variable (weight/SD).
Tropical Medicine and International Health volume 11 no 3 pp 299–313 march 2006
J. D. Njau et al. Fever treatment and household wealth
302 ª 2006 Blackwell Publishing Ltd
differences by SES in religion, age or gender of individuals
interviewed.
Of the individuals completing the detailed survey, 599
(16%) reported a fever episode in the previous 2 weeks,
and 451 of these (75%) had visited at least one provider,
generating data on 557 provider visits. There was signifi-
cant variation in reported fever/malaria by age group:
episodes were most likely to be reported for under fives
(28%), followed by adults (16%), and least likely for older
children (5–14 years) (10%). There was no difference in
reported fever/malaria by SES (Table 3). However, indi-
viduals in the better-off third were significantly less likely
to be parasitaemic on the day of interview. This difference
was particularly pronounced for under fives, of whom 30%
were parasitaemic in the better-off third compared with
45% and 46% in the poorest and middle thirds, respect-
ively (P ¼ 0.007).
Table 3 also shows treatment sought for reported fever/
malaria by SES. The probability of obtaining some kind of
treatment from a provider, home or neighbour was over
80% for all three SES groups, although the better-off third
were somewhat more likely to do so. There was no
significant difference by SES in the probability of visiting
government facilities, drug stores or general shops. How-
ever, households in the better-off third were significantly
more likely to use an NGO facility. Similar patterns of care
seeking across SES were found within the over-five and
under-five age groups; under-fives were more likely than
over-fives to visit facilities and less likely to use general
stores in all SES groups. Visiting traditional healers or
other sources of care was rare for all SES groups.
Only 13% of individuals visited more than one provider,
although two children made five visits each. There was no
significant difference in the mean number of visits between
Table 2 Characteristics of household survey respondents by socio-economic status (SES)
SES thirds
Poorest (%) Middle (%) Better-off (%) Total (%) P-value
Household characteristics
Number of households 362 343 350 1055
Main job of household head:
Farming 352 (98) 316 (92) 267 (76) 935 (89) <0.0001*
Off-farm work 9 (3) 25 (7) 81 (23) 115 (11)
None 0 (–) 1 (0.3) 2 (0.6) 3 (0.3)
Education of household head:
None 128 (37) 115 (35) 68 (20) 311 (31) <0.0001*
Some primary 112 (33) 99 (30) 79 (24) 290 (29)
Completed primary only 95 (28) 101 (32) 130 (39) 329 (33)
More than primary 9 (3) 12 (4) 59 (18) 80 (8)
Religion of household head:
Christian 159 (44) 124 (36) 133 (38) 416 (39) 0.1665
Muslim 199 (55) 216 (63) 216 (62) 631 (60)
Traditional 1 (0.3) 0 (–) 1 (0.3) 2 (0.2)
No religion 3 (0.8) 3 (0.9) 0 (–) 6 (0.6)
Demographic surveillance systems (DSS) area:
Kilombero/Ulanga DSS 206 (57) 177 (52) 202 (58) 585 (55) 0.2140
Rufiji DSS 156 (43) 166 (48) 148 (42) 470 (45)
Individual characteristics
Number of individuals 1139 1245 1313 3697
Age group:
Under 5 years 181 (16) 215 (17) 201 (15) 597 (16) 0.3294
Over 5 years 956 (84) 1029 (83) 1112 (85) 3097 (84)
Gender:
Male 513 (47) 536 (45) 578 (46) 1627 (46) 0.7033
Female 584 (53) 649 (55) 669 (54) 1902 (54)
 Data were missing on household head education for 45 households, main job for two households, age for three individuals and gender for
168 individuals.
 Off-farm work encompassed labourer, business, driver, craftsman, formal sector, traditional healer, lumberjack, charcoal seller and
fishing.
* Significant difference across SES groups (chi-squared test with Rao and Scott’s correction, P < 0.05).
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the SES thirds. Of the 599 people reporting fever/malaria
only four (0.7%) were admitted, one at a government
health centre, two at mission hospitals and one at a mission
dispensary. Of these admissions, two were in the better-off
third, one in the middle and one in the poorest third.
Individuals in the better-off third were significantly more
likely to receive antimalarials than those in the middle or
poorest third, and this differential was even more pro-
nounced when only effective antimalarials were considered
(Table 3). Of all antimalarials dispensed, the proportion
under-dosed did not vary significantly by SES (28% of
antimalarials obtained by the poorest third, 34% by the
middle third and 29% by the better-off third, P ¼ 0.7). As
a result, the probability of obtaining an adequate antima-
larial dose across SES groups followed a similar pattern to
that of obtaining any antimalarials. Antimalarials were
most likely to be obtained during visits to NGO facilities
and least likely at general stores (Figure 1). They were
Table 3 Malaria parasitaemia, reported fever/malaria, treatment sources and drugs obtained
SES thirds
Poorest (%) Middle (%) Better-off (%) Total (%) P-value
Number of individuals 1139 1245 1313 3693
Plasmodium falciparum parasitaemia on the day of interview 249 (25) 283 (26) 202 (18) 734 (23) 0.0001*
Reported fever/malaria in previous 2 weeks 179 (16) 212 (17) 208 (16) 599 (16) 0.6863
Of individuals reporting fever/malaria
Any treatment 149 (83) 170 (80) 190 (91) 509 (85) 0.0067*
Any provider visit 133 (74) 156 (74) 162 (78) 451 (75) 0.5594
Visited government facility 43 (24) 45 (21) 48 (23) 136 (23) 0.8103
Visited NGO facility 5 (3) 7 (3) 27 (13) 39 (7) <0.0001*
Visited any facility 47 (26) 51 (24) 72 (35) 170 (28) 0.0647
Visited drug store 51 (28) 51 (24) 57 (27) 159 (27) 0.6380
Visited general shop 53 (30) 72 (34) 54 (26) 179 (30) 0.2501
Visited traditional healer 2 (1) 2 (1) 0 (–) 4 (0.7) 0.3308
Visited other provider 1 (1) 0 (–) 3 (1) 4 (0.7) 0.2831
Obtained drug from home/neighbour 20 (11) 20 (9) 35 (17) 75 (13) 0.0763
Drugs obtained
Antimalarial 53 (31) 70 (34) 91 (46) 214 (37) 0.0118*
Adequate antimalarial dose 38 (23) 47 (23) 68 (35) 153 (27) 0.0186*
Effective antimalarial 18 (11) 25 (12) 48 (24) 91 (16) 0.0009*
Adequate dose of effective antimalarial 14 (8) 13 (6) 38 (19) 65 (11) 0.0001*
 Data were missing on reported fever/malaria for four individuals.
* Significant difference across SES groups (chi-squared test with Rao and Scott’s correction, P < 0.05).
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Figure 1 Probability of obtaining an
antimalarial drug at provider visits.
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provided at only just over a half of visits to both
government facilities and drug stores.
Treatment seeking was rapid in all SES groups: 78% of
first visits took place within 24 h of the onset of fever/
malaria symptoms, with no significant difference across
SES groups (P ¼ 0.5). On average, the better-off third had
shorter travel times to providers, being significantly more
likely to reach providers within an hour than the poorest
(Table 4). The better-off were more likely to travel by
bicycle and public transport, although the majority in all
groups went by foot. Care seekers spent significantly longer
time at both government and NGO facilities than at shops;
40% and 39% of visits at government and NGO facilities,
respectively, took longer than an hour, compared with 3%
at drug stores and 0 at general shops. There was no
significant relationship between SES and time spent at the
providers (P ¼ 0.9).
Complete cost information was available for 572 indi-
viduals reporting fever/malaria. Of the four individuals
admitted, cost data were missing for one individual, with
the remaining three spending Tshs. 1000.00 (1.12 USD),
5000.00 (5.60 USD) and 15 000.00 (16.85 USD) during
their episoded. Subsequent cost data presented include only
those not admitted. Of the remaining 569 individuals, 188
(33%) spent nothing and there was no significant rela-
tionship between the probability of spending nothing and
SES. For those spending, expenditure per episode ranged
from Tshs. 5.00–4900.00 (0.0056–5.50 USD).
There were significant differences across provider type in
mean expenditure per visit (Table 5). Mean expenditure at
NGO facilities was three times higher than at drug stores,
seven times higher than at government facilities and 16
times higher than at general stores. Median expenditure
was also highest for NGO facilities, but lowest for
government facilities.
The majority of total expenditure in all SES thirds was on
drugs (Figure 2). Transport was the second most important
cost in all thirds, with the remainder spent on food and
lodging and non-drug fees such as registration, consulta-
tion, laboratory tests and syringes. No one reported having
made any kind of informal payment. However, payments
were reported in some government facilities where cost-
sharing had not been introduced, indicating that patients
may have been unaware that payments were unofficial.
Table 6 shows the total cost per episode for all individ-
uals and for only those with some expenditure. For all
individuals, there was no difference between median
expenditure for the poor and middle thirds, but the median
for the better-off was more than three times greater.
Similarly, the mean expenditure for the poorest and middle
thirds was not significantly different, but was significantly
higher for the better-off. The same patterns in median and
mean expenditure were observed when only those who had
incurred some expenditure were considered. The better-off
third spent more partly because they were more likely to
visit NGO facilities and partly because they spent more at
each provider type (Table 3 and Figure 3).
Table 4 Travel time to providers and
mode of transport by SES SES thirds
Poorest
(%)
Middle
(%)
Better-off
(%)
Total
(%) P-value
Number of provider visits
where travel time known
149 183 194 526
Travel time under 1 h 114 (77) 145 (79) 177 (91) 436 (83) 0.0134*
Mode of transport
Travel on foot 126 (85) 139 (76) 133 (69) 398 (76) 0.0314*
Travel by bicycle 23 (15) 40 (22) 53 (27) 116 (22)
Public transport 0 (–) 4 (2) 8 (4) 12 (2)
 Data were missing on travel time for 29 visits; also excludes two cases where lymphatic
filariasis project workers visited the patients at home.
* Significant difference across SES groups (chi-squared test with Rao and Scott’s correction,
P < 0.05).
Table 5 Cost per visit by provider type (TShs)
Number
of
visits
Mean
expenditure
(95% CI) Median Range
Government facility 136 193 (133–253) 25 0–2300
NGO facility 34 1325 (822–1828) 1030 0–4800
Drug store 153 450 (343–557) 270 0–4500
General store 193 80 (63–98) 40 0–1000
d Tshs. 890.00  1.00 USD.
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Table 7 shows variation in total cost per episode by
other household and individual characteristics. Mean and
median expenditures were higher for households in Ki-
lombero/Ulanga DSS area, for those with more educated or
Christian household heads, where the sick individual was
under 5 years or male, and where the illness was perceived
as life threatening. On the basis of these bivariate analyses,
mean expenditure was significantly related to DSS area,
household head education and perceived severity.
Multivariate analysis was used to assess whether SES
had a significant impact on expenditure after controlling
for these other potential determinants (Table 8). A two-
part model of healthcare demand was used to allow for the
high proportion of zero cost observations, and the skewed
distribution of expenditure (Mullahy 1998). Firstly, a Logit
model of whether any expenditure was made found the
only significant explanatory variable to be DSS area, with
households in Kilombero/Ulanga DSS 91% more likely to
spend compared with those in Rufiji DSS. SES was not
significant. Secondly, a log-linear model of total expendi-
ture per episode for those who spent was estimated. The
model included an interaction term between religion and
DSS sites in addition to including both variables separately,
as DSS area and religion of household head were correlated
(correlation coefficient of 0.6) and both may be associated
with expenditure. Although the interaction term was not
statistically significant, its inclusion changed the sign and
significance of the coefficient for religion so it was included
in the final model. Running the regression separately by
DSS area indicated that the change occurred because
religion had a larger impact on expenditure in Rufiji than
in Kilombero and Ulanga DSS sites.
The log linear model had an R2 of 0.2. Total expenditure
per episode was significantly affected by SES (PCA score),
DSS area, religion of the household head and perceived
severity of illness. An increase of 1 in the PCA score led to a
15% increase in expenditure. Residence in Kilombero/
Ulanga DSS increased expenditure by 76%when compared
with those in Rufiji DSS, and being a Christian household
increased expenditure by 64%. Perceiving the illness as life
threatening increased expenditure by 66%. We also tested
quadratic terms for education and PCA scores, neither of
which were significant.
We investigated the importance of a number of potential
strategies to improve affordability for the poor: credit,
payment-in-kind and free facility care. Credit was obtained
at only five visits (0.9%), four at drug stores and one at a
government facility. Of the individuals obtaining credit,
Food & lodging, 6%
Transport, 7%(a) Poorest third
(b) Middle third
(c) Better Off
Non-drug fee, 6%
Drug fee, 81%
Drug fee, 69%
Non-drug fee, 5%
Food & lodging, 5%
Transport, 21%
Non-drug fee, 5%
Transport, 9%
Food & lodging, 9%
Drug fee, 77%
Figure 2 Breakdown of total expenditure by socio-economic
status (SES). (a) Poorest third. (b) Middle third. (c) Better-off.
Table 6 Total cost per episode for all individuals reporting fever/
malaria and for only those with some expenditure (TShs)*
Number
of
episodes
Mean
expenditure
(95% CI) Median Range
For all individuals
Poorest 167 152 (107–196) 30 0–1740
Middle 205 163 (116–210) 30 0–3200
Better-off 197 474 (325–623) 100 0–4900
Total 569 267 (209–325) 50 0–4900
For individuals with some expenditure
Poorest 105 241 (174–308) 100 10–1740
Middle 137 244 (178–310) 100 5–3200
Better-off 139 672 (475–868) 200 10–4900
Total 381 399 (316–482) 120 5–4900
* Excluding the five admissions.
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two were from the poorest third and three from the better-
off third. Payment-in-kind was even less common with
only one occurrence recorded, a supplementary payment to
government facility staff in addition to cash payments for
drug and non-drug fees. Of the 39 NGO facility visits
where drugs were obtained, care was provided free to three
(8%) individuals, one from each SES third. Of the 119
government facility visits where drugs were obtained, free
care was provided at 59 (50%) visits. Individuals were,
unsurprisingly, much more likely to obtain free govern-
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Figure 3 Median expenditure by SES per
provider visit (TShs).
Table 7 Variation in total cost per episode
by household and individual characteristics Number
of
episodes*
Mean
(95% CI) Median Range
Household characteristics
Education of household head
None 156 134 (58–210) 17.5 0–3080
Some primary 145 184 (124–244) 40 0–3200
Completed primary only 190 355 (246–465) 100 0–4500
More than primary 48 620 (217–1024) 100 0–4900
DSS area
Kilombero/Ulanga 273 356 (265–448) 100 0–4900
Rufiji 296 185 (113–257) 20 0–4800
Religion of household head
Christian 205 313 (219–407) 100 0–4900
Muslim 363 239 (165–313) 20 0–4800
Traditional 1 1300 (–) 1300 1300
Individual characteristics
Age group
Under 5 years 154 321 (214–427) 50 0–4900
Over 5 years 415 248 (186–309) 45 0–4800
Gender
Male 232 257 (177–338) 55 0–4900
Female 307 256 (182–329) 30 0–4800
Perceived severity of episode
Life threatening 139 489 (315–662) 100 0–4900
Not life threatening 381 202 (156–247) 40 0–4500
* Of the 569 individuals with complete cost information (excluding those admitted), data
were missing on education for 30 individuals, on gender for 30 individuals and on perceived
severity for 49 individuals.
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ment care in Rufiji DSS where official user fees had not
been introduced (78% compared with 16% in Kilombero/
Ulanga DSS). There was little difference in the probability
of free government care by SES (56% of visits by
individuals in the poorest third, 46% in the middle third
and 48% in the better-off third).
Discussion
Limitations
Self-reported 14 day history of fever is a commonly used
measure in standardised surveys of child health (WHO
2003; Measure 2005; UNICEF 2005). However, it is
subject to a number of limitations. Reporting of both
illness episodes and treatment obtained may be subject to
incomplete recall over the 2-week period. Reported treat-
ment may also have been deliberately misrepresented if use
of certain providers or medicines is perceived as more
socially acceptable. Even in the absence of recall or social
desirability bias, there is some controversy over whether
caretakers can accurately recognise fever in children. For
example, in Guinea, 55% of children reported as febrile
had a normal temperature, and a high temperature was
found in 38% of children identified as sick but afebrile, and
in 13% of children considered healthy (Diallo et al. 2001).
In the Tanzanian setting, these issues were potentially
compounded by the interpretation of homa. While this
term is generally translated as fever, it can apply to a
broader range of symptoms, such as respiratory or
gastrointestinal illnesses (Winch et al. 1994; Tarimo et al.
2000). In such cases, antimalarial treatment may not have
been warranted on the basis of clinical symptoms.
Moreover, of those truly febrile, a high proportion is
likely to have been suffering from non-malarial illnesses.
Facility surveys in the same areas have shown that only
51% of outpatients diagnosed with malaria were parasite
positive at dispensaries, 39% at health centres, and 38% at
hospitals (Causer L.M. et al., unpublished data, IMPACT
Collaboration). Confirmed parasitological diagnosis is
rarely available in such areas, and antimalarial treatment
based on the clinical symptoms alone is in accordance with
national treatment guidelines. However, one could ques-
tion whether it is appropriate to treat all mild fevers in
adults as malaria cases given that their higher levels of
immunity increase the likelihood that these fevers may
have non-malarial causes.
These limitations would be a particular cause for
concern in this analysis if potential biases were not
randomly distributed across socio-economic groups. For
example, it is possible that the better-off, more educated
group were more likely to report illness, had better recall of
treatment obtained, or were more influenced by social
desirability bias. Data were collected only on drugs
obtained; if adherence to doses obtained varied by SES,
relative quality of treatment consumed may have differed
from that obtained. However, other studies in these
districts have not found SES to affect adherence to
treatment obtained (Armstrong Schellenberg et al. 2003;
Kachur et al. 2004). It is also possible that fever episodes
reported were more likely to have been caused by malaria
in poorer groups. Although poorer groups had a higher
parasite prevalence on the day of interview, it was not
possible to assess whether a higher proportion of their
reported fevers was malarial, as some patients who had
experienced malaria in the previous 2 weeks would not
Table 8 Two part model of demand for fever/malaria treatment
Explanatory variables
A: Logit regression model of probability
of having some expenditure
B: Log-linear regression model of total
spending per episode for those with some
expenditure
n ¼ 486 & F ¼ 0.0142 n ¼ 302, R2 ¼ 0.2183 & F ¼ 0.0001
Coefficients [95% CI] Coefficient [95% CI]
Principal components analysis (PCA) score 0.089 )0.025 0.203 0.150 (0.001*) 0.065 0.235
Years of education of the household head 0.012 )0.057 0.082 0.050 )0.008 0.108
Kilombero DSS 0.905 (0.001*) 0.368 1.441 0.756 (0.004*) 0.249 1.262
Christian household head )0.383 )0.939 0.174 0.635 (0.045*) 0.015 1.256
Individual under 5 years 0.031 )0.415 0.478 0.214 )0.144 0.572
Male individual 0.130 )0.255 0.515 0.027 )0.270 0.324
Illness perceived as life threatening 0.456 )0.001 0.914 0.656 (<0.001*) 0.299 1.013
DSS · religion (interaction term) )0.342 )1.123 0.438
Constant 0.247 )0.201 0.695 3.872 (<0.001*) 3.530 4.214
* P-value, statistically significant at 0.05 level.
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have been parasitaemic by the day of interview, and others
who tested positive for parasitaemia may have had low-
density asymptomatic infections.
Socio-economic status was assessed through an asset
index because of the time requirements for collecting
household income or expenditure data, and associated
problems of recall bias and mismeasurement. An oft-cited
advantage of asset indices is that they are not subject to the
seasonal variation that affects expenditure and income
measures. However, this may have been a disadvantage in
this analysis, if treatment choice was influenced by seasonal
variation in cash availability, particularly if such variations
had a relatively large impact on expenditure patterns and
treatment choices for poorer households. Patterns of
treatment seeking across SES groups may also have varied
seasonally if, during the peak malaria season, the better-off
were more likely to avoid long queues at government
facilities.
The Impact of SES
One might have expected variation by SES to be limited, as
these rural DSS areas did not include either small towns or
major urban centres, nor any of Tanzania’s relatively
wealthy agricultural regions. However, despite the homo-
geneity of the study sites, and small sample sizes for some
comparisons, SES variation was clearly evident. Firsty,
individuals in the better-off third were less likely to be
parasitaemic on the day of the interview. Although this did
not translate to a lower rate of reported fever/malaria, one
would expect it to be related to other health consequences,
such as chronic anaemia and low-birth weight.
Secondly, better-off individuals reporting fever/malaria
were significantly more likely to obtain antimalarials, and
in particular to obtain effective antimalarials. Better
treatment resulted in an average expenditure two to three
times greater than that in the poorest or middle thirds. The
better-off spent more because they were more likely to use
NGO facilities, which were the most expensive source of
care, and they also tended to spend more at NGO facilities
and drug stores. However, their indirect costs of travel time
were lower, probably reflecting both their use of faster
means of transport, and a tendency for both providers and
better-off households to be located in market centres
(E. Mwageni, unpublished data, Rufiji DSS). One might
have expected NGO facilities to serve the poorest groups
preferentially. However, most such facilities were obliged
to cover their operating costs fully through user fees, and
their charges were therefore higher than those at govern-
ment facilities. Moreover, most households in the better-
off third would still be considered poor in absolute terms.
There were no significant differences between the poorest
and middle thirds in terms of treatment, drugs obtained or
expenditure, although this may have reflected the limita-
tions of the asset index in distinguishing between the SES
status of poorer households.
In addition to variation by SES, expenditure was also
significantly influenced by household head religion and
DSS area. Christian households were on average not
wealthier, but were clustered around mission-owned NGO
facilities in both DSS sites, which may explain why they
spent more on average than their muslim counterparts.
Residents in Kilombero/Ulanga DSS were more likely to
obtain antimalarials, and spent significantly more on
treatment, than those in Rufiji DSS. The latter’s lower costs
were partly because of the absence of official fees at
government facilities in Rufiji, in contrast to Kilombero/
Ulanga where cost sharing had been introduced in gov-
ernment dispensaries. Lower expenditure in Rufiji also
reflected differences in patterns of retail sector use. Rufiji
residents reporting fever were more likely to visit general
shops than drug stores (35% vs. 22%), whereas Kilomb-
ero/Ulanga residents were more likely to visit drug stores
(24% general shops vs. 32% drug shops). Overall, median
expenditure was almost seven times greater at drug stores
than at general shops. It is possible that greater use of drug
shops in Kilombero/Ulanga reflected a greater demand for
antimalarials, as a result of the longer history of health-
related research and social marketing of insecticide-treated
nets in these areas.
Several similarities with other published studies can be
noted. The finding that SES was positively related to the
probability of obtaining antimalarials, but unrelated to
fever incidence, is supported by other studies from
Tanzania and elsewhere in Africa (Filmer 2002; Armstrong
Schellenberg et al. 2003). Declining parasite prevalence
with an increasing SES has also been documented among
Gambian children (Clarke et al. 2001). The relative cost
per visit across provider types followed a pattern similar to
that observed in Nigeria and Kenya (Amin et al. 2003;
Brieger et al. 2004). However, in contrast to the results
from this study, Ettling et al. (Ettling et al. 1994) found no
consistent relationship between treatment expenditure and
household income in Malawi. This may possibly reflect the
much more limited role of private providers in Malawi at
the time of the study and/or lower fees at NGO facilities
than in Tanzania. It may also be explained by the authors’
categorisation of Malawian households into two groups of
‘very low income’ and ‘low to high income’, whereas we
found that it was the relatively wealthy households that
had significantly different behaviour from the majority. In
multivariate analysis of the determinants of treatment
expenditure for febrile children in rural Benin, Rashed
et al. (2000) found expenditure to be positively and
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significantly related to women’s income, but not to men’s
income nor to a household wealth index, indicating that
the intra-household distribution of income may also be
important in determining treatment received.
An important finding of this study is that the care received
in all SES groups was inadequate. The majority relied on
inadequate public sector provision and the limited antimal-
arials they could purchase from the retail sector. Of those
who had opted for any treatment, only 24% of the poorest,
21%of themiddle and23%of the better-off third visited any
government facility. Moreover, only 8% of the poorest, 6%
of the middle and 19% of the better-off third received an
adequate dose of effective antimalarials. The relatively
better-off obtained better care by paying significantly more
to obtain antimalarials and effective antimalarials at NGO
facilities and drug stores. Under current patterns of provi-
sion, individuals in the poorest andmiddle thirdswould need
to triple their average expenditure per episode to reach the
still inadequate quality of care currently obtained by the
better-off. However, even in the better-off third, under a half
of care seekers obtained an antimalarial, and only 19%
obtained an adequate dose of an effective antimalarial. This
is clearly a Tanzania-wide problem; the nationally repre-
sentative Demographic and Health Survey in 1999 found
only 52% of under fives with fever had received an
antimalarial (National Bureau of Statistics Tanzania,Macro
International Inc. 2000).
It is worth noting that this survey was conducted before
and during the malaria treatment policy change in August
2001. During this period, the availability of antimalarial
drugs other than chloroquine was highly variable. A subse-
quent survey conducted in 2002 showed that, while the
proportion of people obtaining an antimalarial was little
changed (37% in both 2001 and 2002), the proportion of
people receiving effective antimalarials had more than
doubled to 34%, demonstrating the impact of changing first
line drug on the quality of treatment obtained (Kachur S.P.
et al., unpublished data, IMPACT Collaboration).
A range of institutional and market-based mechanisms
could in theory have protected the poorest from the costs of
treatment seeking, but in practice they did not functionwell.
In government facilities, fees were often charged for services
which should have been provided free, and in government
and private facilities, implementation of exemptions ap-
peared limited and haphazard. Credit was rarely given in
practice for fever/malaria treatment whether in the public or
private sector, and payment-in-kind was not practised.
Hausmann-Muela et al. (2000) noted that such mechanisms
were rarely implemented among biomedical care providers.
By contrast, they frequently found traditional healers to
accept compensation in-kind or in work, to allow payment
on a credit basis, or to adjust charges to reflect the patient’s
economic means. Their observation that such traditional
providers were very rarely used for ‘normal’ illnesses such as
malaria was also borne out in this study.
Policy Implications
The results highlight a number of important implications
for Tanzania in advance of the planned introduction of
ACT in 2006. The first concerns access to antimalarials in
the public sector. Based on the current use patterns,
delivery through government facilities will reach only a
quarter of care seekers. Expanding ACT distribution to
NGO facilities would mainly increase accessibility for the
better-off, with public and private facility provision
reaching around one-third of those in the better-off third,
but only a quarter in the poorest or middle thirds.
Provision of a more effective drug might encourage a shift
in use to facilities in each SES group, but it will be
important to monitor this to ascertain whether poorer
groups are accessing effective treatment.
The second implication concerns the issue of extending
access to ACTs beyond the public sector, as recommended
by WHO and the Institute of Medicine (Institute of
Medicine 2004; WHO 2004). ACT use could be increased
by expanding distribution to the retail sector, potentially
through drug stores, which are an established source of
antimalarials and whose staff have some medical training.
One might have expected poorer households to be less
likely to use drug stores, but this study found use to be
relatively constant across SES groups, indicating that
distribution through these outlets would not reach the
better-off alone. However, the study also showed that
drugs were the key drivers of treatment costs in all SES
groups, implying that any increase in drug cost will have a
major impact on affordability for the vast majority.
Achieving high ACT coverage in the retail sector even
among the better-off will therefore be dependent on the
provision of substantial subsidies.
A third implication concerns provision of effective
treatment doses. This study has shown that under-dosing
of antimalarials occurred across all SES groups. All groups
should therefore be targeted with interventions to improve
dosing and adherence, such as pre-packaging, improved
instructions and communication. This is vital if the
additional costs of ACT are to be matched by expected
health outcomes.
Conclusion
The findings of our study have two key implications.
Firstly, the need to improve malaria treatment is not
limited to the choice of an effective first line drug. Only
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a fraction of people reporting fever, <20% overall,
received effective and adequate antimalarials. Recom-
mendations to countries to switch to ACTs must
therefore go hand in hand with strategies to improve
antimalarial coverage and use. Secondly, current rates of
appropriate care and treatment expenditure are positively
related to SES. Our study corroborates previously
reported findings on SES and care seeking, but in
addition demonstrates that better-off respondents were
more likely to receive effective and adequate antimalar-
ials when compared with others. This reflected higher
treatment expenditure in this group, in part because of
their greater use of NGO facilities. This highlights the
importance of including equity issues in debates over the
choice of ACT delivery strategy. Unless we closely
monitor equity outcomes and target our interventions
appropriately, the poorest of the poor may fail to fully
benefit from these new and highly effective medicines.
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Traitement de la fie`vre en fonction des moyens de la famille: le de´fi pose´ pour exclure la the´rapie combine´e dans la malaria
objectif Investiguer les variations dans la parasite´mie de la malaria, les fie`vres rapporte´es, les recours aux soins, les antimalariques obtenus et les
de´penses des familles selon le statut socio-e´conomiques, et e´valuer les implications dans l’assurance d’une utilisation e´quitable et approprie´e de la
the´rapie antimalarique combine´e.
me´thodes 2500 familles ont e´te´ e´tudie´es dans 3 districts ruraux dans le sud de la Tanzanie au milieu de l’anne´e 2001. Des e´chantillons de sang et les
donne´es sur le statut socio-e´conomique ont e´te´ collecte´s dans toutes les familles. Une moitie´ des participants a comple´te´ un questionnaire de´taille´ sur le
recours aux soins et le couˆt des traitements. Les familles ont e´te´ reparties par cate´gories selon le statut socio-e´conomique sur base d’un index de richesse
de famille de´rivant d’analyse de composant principaux.
re´sultats 16% des individus ayant comple´te´ le questionnaire de´taille´ ont rapporte´ un e´pisode de fie`vre au cours des deux semaines pre´ce´dentes. Les
personnes dans la cate´gorie a` moyens e´leve´s avaient significativement moins de parasite´mie et e´taient significativement plus susceptible d’obtenir des
antimalariques compare´es a` celles dans les cate´gories interme´diaires ou pauvres. Un meilleur traitement couˆtait aux personnes de la cate´gorie a` moyens
e´leve´s 2–3 fois plus cher que pour les personnes dans les cate´gories interme´diaires et pauvres. Ceci refle`te un recours plus e´leve´ aux services des ONG qui
sont plus couˆteux et donc une plus grande de´pense dans les services des ONG et dans les de´poˆts pharmaceutiques.
conclusion La couverture d’un traitement approprie´ de la malaria e´tait basse quel que soit le statut socio-e´conomique du groupe. Mais, les deux
cate´gories les plus pauvres e´taient particulie`rement de´savantage´es. A l’heure ou` les pays se tournent vers une the´rapie combine´e de la malaria, la
distribution des me´dicaments devrait eˆtre cible´e afin de s’assurer que les plus pauvres puissent be´ne´ficier de ces nouveaux me´dicaments tre`s actifs.
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Tratamiento de la fiebre y patrimonio familiar: el reto que supone el poner en marcha la terapia de combinacio´n para malaria
objetivo Investigar la variacio´n en la parasitemia de malaria, la fiebre reportada, la bu´squeda de cuidados de salud, los antimala´ricos obtenidos y el
gasto familiar por estatus socio-econo´mico, y evaluar las implicaciones para asegurar un uso equitativo y apropiado de la terapia de combinacio´n para la
malaria.
me´todo Se entrevistaron 2500 hogares en tres distritos rurales del sur de Tanzania a mediados del 2001. Se tomaron muestras de sangre y datos sobre
el estatus socio-econo´mico de todos los hogares. La mitad completo´ un cuestionario detallado sobre la bu´squeda de cuidados y los costes de tratamiento.
Las familias se catalogaron segu´n su estatus socio-econo´mico basa´ndose en un ı´ndice de riqueza familiar obtenido con un ana´lisis de componentes
principales.
resultados De los individuos que completaron el cuestionario detallado, un 16% reporto´ un episodio de fiebre en las dos semanas anteriores. Las
personas del estrato social ma´s elevado tenı´an significativamente una probabilidad mas baja de ser parasite´micos y una probabilidad ma´s alta de obtener
antimala´ricos, que aquellos en los estratos medio o bajo. El mejor tratamiento cuesta al menos dos a tres veces ma´s que lo gastado por los estratos medio
y bajo. Esto refleja un mayor uso de instalaciones de ONG, que eran la fuente de cuidados ma´s costosa, y un mayor gasto en las instalaciones de las
ONG y las farmacias.
conclusio´n La cobertura de un tratamiento apropiado para la malaria era baja en todos los estratos socio-econo´micos, pero los dos ma´s pobres
estaban particularmente en desventaja. A medida que los paı´ses hacen el cambio a una terapia de combinacio´n, la distribucio´n debe ser focalizada, con el
fin de asegurar que los grupos ma´s pobres se benefician plenamente de estos medicamentos nuevos y altamente eficaces.
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